2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide

C19H18N8OS — CID 138589710

IUPAC2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide
SMILESCc1cn2c(n1)CN(C(=O)Nc1cc3nc(-c4nnc(C)s4)ccc3cn1)CC2
InChIInChI=1S/C19H18N8OS/c1-11-9-26-5-6-27(10-17(26)21-11)19(28)23-16-7-15-13(8-20-16)3-4-14(22-15)18-25-24-12(2)29-18/h3-4,7-9H,5-6,10H2,1-2H3,(H,20,23,28)
InChIKeyZUCMHZLVQVSDII-UHFFFAOYSA-N
MW406.48 g/mol
LogP3.01
Rot. Bonds2

About 2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide

2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide (PubChem CID 138589710) has the molecular formula C19H18N8OS and a molecular weight of 406.48 g/mol. Its IUPAC name is 2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide.

Molecular Properties

Compound Name2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide
PubChem CID138589710
Molecular FormulaC19H18N8OS
Molecular Weight406.48 g/mol
Exact Mass406.13
IUPAC Name2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide
SMILESCc1cn2c(n1)CN(C(=O)Nc1cc3nc(-c4nnc(C)s4)ccc3cn1)CC2
InChIInChI=1S/C19H18N8OS/c1-11-9-26-5-6-27(10-17(26)21-11)19(28)23-16-7-15-13(8-20-16)3-4-14(22-15)18-25-24-12(2)29-18/h3-4,7-9H,5-6,10H2,1-2H3,(H,20,23,28)
InChIKeyZUCMHZLVQVSDII-UHFFFAOYSA-N
XLogP3.01
TPSA101.72 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds2
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500406.48
LogP ≤ 53.01
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze 2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide?
The IUPAC name of 2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide (CID 138589710) is 2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide.
What is the SMILES notation for 2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide?
The canonical SMILES for 2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide is Cc1cn2c(n1)CN(C(=O)Nc1cc3nc(-c4nnc(C)s4)ccc3cn1)CC2.
What is the InChIKey of 2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide?
The InChIKey is ZUCMHZLVQVSDII-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H18N8OS/c1-11-9-26-5-6-27(10-17(26)21-11)19(28)23-16-7-15-13(8-20-16)3-4-14(22-15)18-25-24-12(2)29-18/h3-4,7-9H,5-6,10H2,1-2H3,(H,20,23,28).
What are the key properties of 2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide?
2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide has a molecular weight of 406.48 g/mol, XLogP of 3.01, 2 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-methyl-N-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,6-naphthyridin-7-yl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxamide is sourced from PubChem (CID 138589710), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).